Oculis Holding AG announced on June 5, 2025, the results of its 2025 Annual General Meeting, held on June 4, 2025. Shareholders approved all agenda items, including the 2024 Annual Report, the 2024 Annual (Statutory) Financial Statements, and the 2024 Consolidated Financial Statements.
The company acknowledged a standalone statutory financial statement loss of CHF 5,179,000 for the financial year ended December 31, 2024, with an accumulated balance sheet loss of CHF 46,577,000 carried forward. The Board of Directors and Executive Committee members were granted discharge for their activities in 2024, and all existing board members, including Chairman Anthony Rosenberg, were re-elected.
Shareholders also approved a capital band of 27,266,837 registered shares, resulting in a capital band between CHF 545,336.74 and CHF 818,005.11. Additionally, a conditional share capital for employees and comparable positions was approved in the maximum amount of CHF 124,800, through the issuance of 12,480,000 registered shares, along with related amendments to the articles of association.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.